Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9675704 Modified release formulations containing drug-ion exchange resin complexes

Patent 9675704 was granted and assigned to Tris Pharma on June, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

Edits on 16 Oct, 2024

"update inverses"

edited on 16 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

"update inverses"

edited on 16 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

"update inverses"

edited on 16 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

"update inverses"

edited on 16 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12115142 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

Edits on 9 Oct, 2024

"update inverses"

edited on 9 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12109186 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

Edits on 4 Sep, 2024

"update inverses"

edited on 4 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12076441 Extended release amphetamine tablets

0

Edits on 22 May, 2024

"update inverses"

edited on 22 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11986451 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

Edits on 29 Mar, 2024

"update inverses"

edited on 29 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11938224 Benzonatate modified release solid tablets and capsules

0

Edits on 12 Mar, 2024

"update inverses"

edited on 12 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11918689 Liquid clonidine extended release composition

0

Edits on 9 Feb, 2024

"update inverses"

edited on 9 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11890267 Benzonatate modified release solid tablets and capsules

0

Edits on 13 Dec, 2023

"update inverses"

edited on 13 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11839597 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

Edits on 6 Dec, 2023

"Add patent abstract"

edited on 6 Dec, 2023

Edits made to:

Article (+303 characters)

Article

Patent abstract

A particulate, pH-independent, modified release barrier coated drug-cation exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. Methods of making and products containing this coated complex are described.

Edits on 11 Oct, 2023

"update inverses"

edited on 11 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Edits on 27 Sep, 2023

"update inverses"

edited on 27 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Edits on 26 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 26 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=0967570400

Edits on 18 May, 2023

"Remove leading 0 from patent number"

edited on 18 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09675704 Modified release formulations containing drug-ion exchange resin complexes US Patent 9675704 Modified release formulations containing drug-ion exchange resin complexes

Infobox

Patent Number

0967570400

Patent Number

967570400

Edits on 22 Mar, 2023

"Entity importer update"

edited on 22 Mar, 2023

Infobox

Is a

0

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

096757040

Date of Patent

June 13, 2017

0

Patent Application Number

152007860

Date Filed

July 1, 2016

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=096757040

Patent Primary Examiner

0

Edits on 26 Sep, 2022

"Entity importer update"

edited on 26 Sep, 2022

Infobox

Is a

0

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

096757040

Date of Patent

June 13, 2017

0

Patent Application Number

152007860

Date Filed

July 1, 2016

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=096757040

Patent Primary Examiner

0

Edits on 15 Jun, 2022

"Entity importer update"

edited on 15 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09675704

Find more entities like US Patent 9675704 Modified release formulations containing drug-ion exchange resin complexes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool